Stroke Trial, Recruiting NCT04746820 Sponsor: Emanuela Keller Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04746820
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Main patient group (experimental group):

  • People of any gender who have had a severe bleeding or blockage stroke, or brain injury caused by lack of oxygen after cardiac arrest and resuscitation, and are being treated at the Institute of Intensive Care Medicine at University Hospital Zurich
  • People who are unconscious or sedated due to the severity of their illness, with a low level of consciousness (confirm with trial site for specific scoring details)
  • People aged 18 or older
  • People whose legal representative has signed a consent form on their behalf
  • People for whom the measurements can be carried out within the first 7 days after admission

Comparison group (control group):

  • People of any gender who are fully conscious and alert
  • People aged 18 or older
  • People who have signed a consent form themselves

Who may not be able to join:

Main patient group (experimental group):

  • People under the age of 18
  • Women who are pregnant or breastfeeding
  • People who have had previous hearing problems or any ear conditions
  • People in whom a specific nerve response test (called SSEP at Erb's point) shows no detectable signal, for example due to nerve or tissue damage (confirm with trial site)
  • People with any history of previous brain or brainstem disease
  • People who also have another unstable serious illness at the same time, such as severe infection, multiple organ failure, or unstable heart or breathing function
  • People currently experiencing continuous seizure activity
  • People who have already recovered sufficiently or passed away before being enrolled in the study

Comparison group (control group):

  • People under the age of 18
  • Women who are pregnant or breastfeeding
  • People who have had previous hearing problems or any ear conditions
  • People in whom a specific nerve response test (called SSEP at Erb's point) shows no detectable signal (confirm with trial site)
  • People with any history of previous brain or brainstem disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emanuela Keller, Prof. Dr., University Hospital, Zürich

Phone: +41 44 255 56 71

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Emanuela Keller
Registry
ClinicalTrials.gov
Start date
15 January 2020
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Results of fNIRS examination to those of evoked potentials (presence or absence of response) in unconscious ICU patients with severe hemorrhagic, ischemic strokes or hypoxic brain injury after cardiac arrest and cardiopulmonary resuscitation.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov